Results 141 to 145 of about 1,795 (145)

Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada

Haemophilia, 2023
exaly  

Emicizumab for non-severe haemophilia A

The Lancet Haematology, 2023
openaire   +2 more sources

Emicizumab for infants and children with haemophilia A

British Journal of Haematology, 2020
openaire   +2 more sources

Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors—a single‐center cohort

Pediatric Blood and Cancer, 2019
Tami Livnat, Ivan Budnik, Assaf Barg
exaly  

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab

Journal of Thrombosis and Haemostasis, 2018
Keiji Nogami
exaly